| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |